Advertisement

Program Helps Enhance Pharmacist Knowledge of Real-World Evidence

Researchers developed a novel real-world evidence (RWE) training program for pharmaceutical company field medical professionals to build competency in RWE research concepts and found...

Digital Therapeutic Helps Treat Opioid Use Disorder with Minimal Budget Impact

reSET-O is the first FDA-approved prescription digital therapeutic for the treatment of patients with opioid use disorder in combination with usual treatment (e.g., buprenorphine)....

Incorporating Digital Therapeutics into Utilization Management Practices

Utilization management practices play an important role in optimizing and driving utilization patterns toward clinically- and cost-effective products, but the application of inappropriate exclusions can negatively...

How Digital Therapeutics Can Optimize Care for Various Conditions

Digital therapeutics are emerging as a novel treatment modality for a wide range of health conditions, either alone or in conjunction with other treatments....
Advertisement